ANTIBODY-DEPENDENT ENHANCEMENT

This adverse event was reported 1 times

These drugs are most commonly taken by patients reporting ANTIBODY-DEPENDENT ENHANCEMENT:

# Drug Count
0 NIRSEVIMAB 1
See all common drugs associated with ANTIBODY-DEPENDENT ENHANCEMENT

ANTIBODY-DEPENDENT ENHANCEMENT is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 NIRSEVIMAB 1 0.0006
See all drugs enriched for association with ANTIBODY-DEPENDENT ENHANCEMENT

These drug classes are most commonly taken by patients reporting ANTIBODY-DEPENDENT ENHANCEMENT:

# Drug class Count
0 Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] 1
See all common drug classes associated with ANTIBODY-DEPENDENT ENHANCEMENT

ANTIBODY-DEPENDENT ENHANCEMENT is most prevalent among patients taking these drug classes:

# Drug class Count Frequency
0 Respiratory Syncytial Virus Anti-F Protein Monoclonal Antibody [EPC] 1 0.0006
See all drug classes enriched for association with ANTIBODY-DEPENDENT ENHANCEMENT